Tag
$HEXO
- Tilray Brands revenue goes up 20% YoY to $184M in Q4
- Tilray reports $1.1B in losses during Q3 2023, acquires Hexo for $75M
- HEXO reports Q4 net revenue decrease of 7% to $42.5M
- Hexo to produce Mike Tyson's new pot brand in Canada
- Deep in debt, Hexo hemorrhages $146.66 million in Q3
- Hexo slashes 230 jobs after Belleville facility shutdown
- Hexo reports $616M write-down in Q1
- Hexo defaults on senior debt, but lender waives event due to Tilray deal
- Hexo refreshes board, reaches deal with activist shareholder
- Hexo suggests share consolidation to stay on Nasdaq
- Hexo shareholder calls for board replacements as share price tanks
- Hexo's sales spike 31% with $117M loss after steep impairments in Q1
- Hexo to shutter 3 production sites in early 2022
- Hexo reaches new highs this quarter, yearly sales up 57%
- Hexo co‑founder and CEO exits after rocky ride
- Hexo and Molson Coors expand CBD drinks to 17 states
- Hexo says it's offset 100% of its carbon emissions
- Ontario Cannabis Store posts huge growth in 2nd‑annual fiscal report
- Hexo to buy 48North Cannabis for $50M
- Hexo to enter US weed market with Colorado facility
- Aurora stock falls amid more large losses and cost cuts
- Hexo touts Q2 earnings, eyes M&A
- Is Hexo blowing smoke on Euro entry via Zenabis deal?
- Hexo to enter Europe with $265M Zenabis acquisition
- TerrAscend expands gummy recall following complaints 'alleging' mould
- Hexo, Molson Coors launch first US CBD drinks in Colorado
- Hexo cuts losses, bets big on pot drinks
- Plain packaging rules add to deceiving high‑THC hype, pot prof says
- Pot stock leaders to consider ahead of US election: BCMI
- Molson and Hexo joint venture Truss launches 5 new weed drinks
- Aphria joins Israeli medical cannabis rush with new supply deal
- Hexo makes first international medical weed shipment to Israel
- Hexo says profits depend on more pot shop openings in Ontario, Quebec
- Corporate cannabis continues value brand pivot as Canada enters recession
- Hexo introduces 30‑gram weed product for medical patients
- 'Huge chunk' of Canada's 383 weed companies won't survive this year: investment banker
- As cannabis bankruptcies accelerate during pandemic, lawyer says survivors will thrive long term
- MediPharm blames slow cannabis 2.0 rollout for Q4 revenue drop
- Hexo reports $300M in losses, claims value product is beating black market
- Canadian pot industry could take lessons from Colorado's success: expert
- Inner Spirit opens more Alberta pot shops, eyes Ontario expansion
- Illicit pot market now 44% cheaper than legal industry: StatsCan
- Hexo drops on share offering, inventory writedown
- Year in review: Top 8 cannabis stories of 2019
- HEXO reports $62.4 million loss in latest quarter
- American investors sue Aurora Cannabis and HEXO for misleading them
- HEXO's black market-disrupting cannabis Original Stash hits shelves on Black Friday
- Segra granted nursery licence, moves forward with hyper-efficient cloning tech
- Hexo shares on rollercoaster ride after company reveals unlicensed cannabis
- Aleafia Health's first outdoor crop produces cheapest cannabis in country